ruchika, Medical Dialogues

Top

Dermatology

facebook
twitter

Sign in Signup

This site is intended for healthcare professionals only

facebook
twitter

Sign in Signup

Medical Jobs
Medical Matrimony
MD Brand Connect
Corona Updates

Medical News
Health news
Medical Guidelines
AYUSH
State News
Medical Education
Industry

This site is intended for healthcare professionals only

Sign In Register

Sign inRegister

Home
Medical news
Health news
Medical Guidelines
Medical Education
Industry
Case of the Day
Editorial

ruchika

Ruchika joined Medical Dialogue an Desk Editor for the Business Section in 2019. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home
ruchika

Articles By : ruchika

No data from late-stage trial of COVID-19 vaccine, says Pfizer

ruchika28 Oct 2020 7:37 AM GMT

New Delhi: Drugmaker Pfizer Inc said on Tuesday it does not yet have data from the late stage trial of the COVID19 vaccine it is developing with G...

Tri-Activ Disinfectant Spray for multi-surface effective against Covid: Piramal Pharma

ruchika28 Oct 2020 7:25 AM GMT

Mumbai: Piramal Pharma Limited's Consumer Products Division has recently announced that its Tri-Activ Disinfectant Spray for multi-surfaces is '99.9% e...

COVID-19: Piyush Goyal calls upon global community to ensure availability of affordable vaccines

ruchika28 Oct 2020 6:39 AM GMT

New Delhi: Commerce and Industry Minister Piyush Goyal on Tuesday called upon the global community to ensure timely and equitable availability of ...

Granules, Laurus Labs to invest Rs 700 crores for setting up Greenfield facilities

ruchika28 Oct 2020 6:13 AM GMT

Rama Rao thanked the leadership of both the companies for choosing to invest in Telangana and said the state government would provide all possible...

Setback: Eli Lilly antibody drug fails in a Covid19 study, others go on

ruchika27 Oct 2020 8:50 AM GMT

Annapolis: US government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalised with Covid-19 because...

Cadila in talks with potential partners to ramp up COVID vaccine production: Report

ruchika27 Oct 2020 7:28 AM GMT

New Delhi: Cadila Healthcare Ltd., one of two Indian drugmakers racing to develop an indigenous Covid-19 vaccine, is in talks with potential partners t...

Gland Pharma receives SEBI nod to launch IPO

ruchika27 Oct 2020 6:14 AM GMT

According to investment banking sources, the IPO would be worth over Rs 5,000 crore.

Torrent Pharma net profit rises 27 percent at Rs 310 crore in Q2

ruchika27 Oct 2020 5:30 AM GMT

New Delhi: Drug firm Torrent Pharmaceuticals on Monday reported a 27.04 per cent rise in consolidated net profit to Rs 310 crore for the quarter e...

Bayer Acquires Asklepios BioPharmaceutical to expand Cell, Gene Therapy base

ruchika27 Oct 2020 4:30 AM GMT

Berlin: Bayer AG has recently announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company spe...

SEBI imposes fine on Biocon's regulatory affair officer for insider trading

ruchika26 Oct 2020 9:48 AM GMT

Mumbai: In a major setback to Biocon Ltd., markets regulator Securities and Exchange Board of India (SEBI)on Friday levied a fine on an employee attach...

NPPA sets up price monitoring, resource unit in Goa

ruchika26 Oct 2020 7:30 AM GMT

New Delhi: A price monitoring and resource unit has been set up in Goa under the aegis of the National Pharmaceutical Pricing Authority (NPPA), the gov...

Aurobindo Pharma to sell US arm to New Mountain Capital for Rs 4,048 crore

ruchika26 Oct 2020 7:00 AM GMT

The proceeds from Natrol's divestiture will be used to reduce debt and other new strategic initiatives.

Powered By: Hocalwire

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok

X